|Bid||3.7300 x 0|
|Ask||3.7500 x 0|
|Day's Range||3.6400 - 3.7600|
|52 Week Range||2.0400 - 5.9200|
|Beta (3Y Monthly)||2.69|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.15|
Cannabis Updates: New Listings, Price Action, and Ratings(Continued from Prior Part)Cannabis The cannabis sector (HMMJ) closed in the red last week. Let’s see how analysts are rating some of the major cannabis players and analyze the changes last
Cannabis Updates: New Listings, Price Action, and RatingsCannabis updateThe cannabis sector showed some weakness last week, and the Horizons Marijuana Life Sciences ETF (HMMJ) lost 3.0% while the ETFMG Alternate Harvest ETF (MJ) lost 3.4%.
Why Did Cannabis Stocks Fall on April 15?(Continued from Prior Part)Cannabis stocks Cannabis stocks were deep in the red on April 15. The sector is known for high volatility. Stocks in the cannabis space are more volatile compared to broader
Why Did Cannabis Stocks Fall on April 15?Cannabis stocksCannabis stocks were broadly in the red on April 15. Charlotte’s Web Holdings (CWBHF) saw a negative price action of 5.8%. Looking at other stocks, Emerald Health Therapeutics (EMH), Supreme
NEW YORK, April 15, 2019 /CNW/ -- As the cannabis industry has expanded, the methods of ingestion have also changed. The medical benefits of cannabis have allowed the industry to grow rapidly over the past several years with Canada even legalizing cannabis entirely for both medical and recreational use just last year. Then, one month later, U.S. states Michigan, Missouri, and Utah legalized cannabis on some form, bringing the number of states with cannabis legislation to a total of 33, as well as the District of Columbia.
HOUSTON, TX / ACCESSWIRE / April 9, 2019 / Controversial or not, it's tough to ignore the cannabis boom. Just over the last two years, it's been responsible for transforming multi-billion-dollar industries, ...
OTCQX: EMHTF), a licensed producer of cannabis products for medical and recreational purposes, announced today that executives of the company will participate in multiple upcoming investment conferences.
OTCQX: EMHTF) today announced that its Québec facility, Verdélite, has received its Standard Processing License from Health Canada. This license means that, in addition to Verdélite’s right to cultivate and sell cannabis flowers, it can now extract, manufacture, synthesize, test and sell next-generation cannabis products and will position Verdélite to launch these products in conjunction with the expected legalization of a broader spectrum of cannabis products in Canada in October 2019.
iAnthus Capital Holding (CNXS:IAN) and Emerald Health Therapeutics (TSXV:EMH) are largely flying under the radar, but this is why you should keep tabs on both stocks.
Thanks to recently passed U.S. legislation, business is about to pick up for licensed Canadian cannabis producer Village Farms International Inc (TSX:VFF)(NASDAQ:VFF).
How Medical Marijuana Stocks Performed on April 4(Continued from Prior Part)Medical marijuana stocks The cannabis sector saw some weakness on April 4. The ETFMG Alternate Harvest ETF (MJ) saw a negative price action of 0.11%. Charlotte’s Web
PALM BEACH, Florida, April 4, 2019 /CNW/ -- A recent report from an independent, technology-driven analytics company specializing in the cannabis industry stated that: "… the global hemp industry reached $3.7 billion USD in retail sales in 2018, with an annual growth rate of 15% driven by continued strength in Chinese textiles, European industrials, Canadian foods, and the U.S. hemp-derived CBD market. China led all countries with nearly $1.2 billion USD in hemp sales in 2018, followed by the United States ($1.0 billion), Europe ($980 million) and South and Central America ($220 million). The U.S. market is positioned to grow under the 2018 Farm Bill, with an estimated $2.6 billion projected in sales by 2022, with $1.3 billion in sales estimated for hemp-derived CBD products by 2022. "As regulatory barriers diminish in the months and years ahead, businesses will continue to expand the ways in which hemp is utilized, especially across medicinal and industrial applications," said (the author).
A recent news release indicates that Emerald Health Therapeutics Inc. (OTCMKTS:EMHTF) will expand its market share in supplying cannabis. Notably, the firm intends to be the cannabis supplier for Société Québécoise du Cannabis (SQDC) after signing a letter of intent. In the letter, Emerald agreed to deliver the first shipment during Q2 2019. Emerald Health […]The post Opportunities For Emerald Health Continue To Expand After Expansion Of Production Capacity appeared first on Market Exclusive.
OTCQX: EMHTF) has signed a letter of intent to supply cannabis to the Société Québécoise du Cannabis (SQDC), Quebec's sole legal distributor of recreational cannabis. Under the agreement, Emerald will supply cannabis to the SQDC from its Québec-based Saint-Eustache facility, Verdélite, as well as from its 50%-owned joint venture, Pure Sunfarms, in Delta, BC. Emerald will fulfill its first supply order in Q2 2019. “Québec’s population of 8.4 million is a sizable market and we are pleased to be able to offer locally-grown, quality cannabis products to the adult-use consumers throughout the province,” said Dr. Avtar Dhillon, President and Executive Chairman of Emerald.
NEW YORK, April 2, 2019 /CNW/ -- The proliferation of cannabidiol, or CBD-based products, has exploded after U.S. President Donald Trump signed the Farm Bill in December 2018. Now, CBD products are appearing at supermarkets, health and wellness stores, smoke shops, coffee shops, and farmer's markets around the country. Due to the rapid emergence of the industry, CBD products have expanded outwards from traditional oils and tinctures to shampoos, bath bombs, pet treats, and gummy bears.
Emerald Health Therapeutics (OTCMKTS:EMHTF) has announced that they have fulfilled their first Yukon Liquor Corporation cannabis purchase order and the signing of a sales agreement with Alberta Gaming Liquor and Cannabis. Emerald to supply five provinces They have also been registered officially by the Saskatchewan Liquor and Gaming Authority to supply the Saskatchewan market with […]The post Emerald Health Fulfills Yukon Purchase Order, Alberta Supply Agreement appeared first on Market Exclusive.
OTCQX: EMHTF) today announced that its 50%-owned joint venture, Pure Sunfarms, has exercised its option to acquire from Village Farms International, Inc. (“Village Farms”) a second 1.1 million square foot (25 acre) greenhouse (“Delta 2”) adjacent to Pure Sunfarms’ existing 1.1 million square foot cannabis operation (“Delta 3”) in Delta, BC. Pure Sunfarms expects to reach its annualized full production run-rate of approximately 75,000 kilograms by mid-year at Delta 3 and expects to double its overall production on completion of the conversion of Delta 2. Emerald has also entered into an agreement with Pure Sunfarms to purchase 25% of its aggregate cannabis production from Delta 3 and Delta 2 in 2020, 2021 and 2022.
OTCQX: EMHTF) has fulfilled its first purchase order of cannabis from Yukon Liquor Corporation, signed a sales agreement with Alberta Gaming, Liquor and Cannabis (AGLC), and become officially registered by the Saskatchewan Liquor and Gaming Authority (SLGA) to supply cannabis to the Saskatchewan market. “We are pleased to provide our Emerald-branded cannabis products to the adult-use markets in Alberta, Saskatchewan and the Yukon,” said Dr. Avtar Dhillon, President and Executive Chairman of Emerald.
OTCQX:EMHTF) today announced that it has established an at-the-market equity program (“ATM Program”) that allows the Company to issue common shares from treasury (“Common Shares”) having an aggregate gross sales price of up to $39 million to the public from time to time, at the Company’s discretion, at the prevailing market price when issued on the TSX Venture Exchange (“TSXV”) or on any other marketplace for the Common Shares in Canada. The ATM Program is effective until the earlier of April 13, 2021 or completion of the sale of the maximum amount of shares thereunder and will be activated from time to time at the Company’s discretion if and when required based on the Company’s working capital requirements and capital expenditures and relative cost of other funding options.
NEW YORK, March 26, 2019 /CNW/ -- Following Canada's legalization of cannabis and the U.S.'s ongoing efforts, cannabis-based companies have seen their revenue grow substantially over the past few years. In the past quarter alone, major events had occurred within the North American region, bolstering the cannabis industry further. Last year in October, Canada legalized cannabis entirely for both medical and recreational use.
PALM BEACH, Florida, March 21, 2019 /CNW/ -- An industry publication recently said that, in both Canada and the U.S.: "The future is very bright for property owners in North America as cannabis companies are on the hunt for cannabis retail locations." The article said that: "Cannabis retailers aren't very widespread in Canada as most provincial governments are slow to roll out the licenses needed to open the stores. In other developments in the industry, a recent headline projecting what will happen in the 2019 cannabis markets, used a tongue-in-cheek cliché: "High Times Ahead: Continued Dramatic Growth Expected For The Legal Cannabis Industry In 2019." High times are indeed projected.
OTCQX: EMHTF) applauds the Government of Canada for proposing to amend the excise tax calculation for cannabis in the federal budget announced yesterday. The implementation of the proposed revision announced in the federal budget would result in the calculation of the excise duty of ingestible cannabis and hemp products being based on the quantity of THC in the products, as opposed to the current tax set in relation to the product volume.